Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
O-I Glass | OI | 9. mai 2024 | 13.45 | +0.37 |
Oak Valley Bancorp | OVLY | 9. mai 2024 | 23.90 | -0.58 |
Oak Woods Acquisition | OAKU | 9. mai 2024 | 10.77 | -0.09 |
Oaktree Capital A Pref | OAK-A | 9. mai 2024 | 22.08 | +1.30 |
Oaktree Capital Group B Pref | OAK-B | 9. mai 2024 | 21.85 | +1.11 |
Oaktree Specialty | OCSL | 9. mai 2024 | 19.20 | +0.37 |
Oatly ADR | OTLY | 9. mai 2024 | 1.26 | +5.00 |
Oblong | OBLG | 9. mai 2024 | 0.11 | -0.44 |
OCA Acquisition A | OCAX | 9. mai 2024 | 10.96 | 0.00 |
Occidental Petroleum | OXY | 9. mai 2024 | 64.24 | +0.88 |
Ocean Biomedical | OCEA | 9. mai 2024 | 1.74 | -0.57 |
Ocean Power Technologies | OPTT | 9. mai 2024 | 0.20 | +3.16 |
Oceaneering International | OII | 9. mai 2024 | 23.75 | +1.63 |
OceanFirst Financial | OCFC | 9. mai 2024 | 15.69 | +0.71 |
OceanFirst Pref | OCFCP | 9. mai 2024 | 24.47 | -0.20 |
OceanPal | OP | 9. mai 2024 | 2.60 | +4.42 |
Ocugen | OCGN | 9. mai 2024 | 1.67 | -2.91 |
Ocular Therapeutix | OCUL | 9. mai 2024 | 5.84 | +1.57 |
Oculis | OCS | 9. mai 2024 | 11.97 | -3.27 |
Ocuphire Pharma | OCUP | 9. mai 2024 | 1.96 | +7.10 |
Ocwen Financial | OCN | 9. mai 2024 | 27.06 | +0.04 |
Oddity Tech | ODD | 9. mai 2024 | 38.01 | +4.17 |
Odyssey Marine Exploration | OMEX | 9. mai 2024 | 3.98 | -0.50 |
Offerpad Solutions A | OPAD | 9. mai 2024 | 6.68 | -2.62 |
Office Properties | OPI | 9. mai 2024 | 2.27 | -1.30 |
OFG Bancorp | OFG | 9. mai 2024 | 38.14 | -0.05 |
OFS Capital | OFS | 9. mai 2024 | 9.52 | 0.00 |
OFS Credit | OCCI | 9. mai 2024 | 7.44 | +0.95 |
OFS Credit C Pref | OCCIO | 9. mai 2024 | 24.13 | +0.50 |
OFS Credit E Pref | OCCIN | 9. mai 2024 | 23.15 | -0.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.